论文部分内容阅读
目的观察芪冬颐心口服液对急性心肌梗死(AMI)患者临床疗效的影响。方法 280例急性心肌梗死患者,随机分为对照组和试验组,每组140例。对照组给予常规治疗,试验组在常规治疗的基础上给予芪冬颐心口服液,观察两组患者治疗后临床疗效。结果治疗后,试验组患者总有效率为92.9%(130/140),高于对照组的85.0%(119/140),差异具有统计学意义(P<0.05)。结论芪冬颐心口服液可显著提高急性心肌梗死患者临床疗效,值得临床进一步推广运用。
Objective To observe the effect of Qi Dong Yi Xin oral liquid on the clinical efficacy of patients with acute myocardial infarction (AMI). Methods 280 patients with acute myocardial infarction were randomly divided into control group and experimental group, 140 cases in each group. The control group was given routine treatment. The experimental group was given Qidudong Yi Xin oral liquid on the basis of routine treatment, and the clinical curative effect was observed after treatment. Results After treatment, the total effective rate of the experimental group was 92.9% (130/140), which was higher than that of the control group (85.0%, 119/140). The difference was statistically significant (P <0.05). Conclusion Qidong Yi Xin oral liquid can significantly improve the clinical efficacy of patients with acute myocardial infarction, it is worth further clinical application.